Bayer AG (WAR:BAY) Net Interest Margin (Bank Only) %


WAR:BAY Bayer AG WAR:BAY
44 GF Score
Price zł205.30
GF Value zł116.27
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bayer AG Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

WAR:BAY
44GF Score
Bayer AG WAR:BAY
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (WAR:BAY) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of zł205.30 is trading 76.6% above its estimated GF Value™ of zł116.27. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WAR:BAY:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: zł116.27 vs. price of zł205.30 (76.6% above fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the WAR:BAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
44GF Score

Get the complete analysis for WAR:BAY

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł205.30
Price
zł116.27
GF Value